| Literature DB >> 24726029 |
Marcus Gadau, Wing-Fai Yeung, Hua Liu, Chris Zaslawski, Yuan-Sheng Tan, Fu-Chun Wang, Sergio Bangrazi, Ka-Fai Chung, Zhao-Xiang Bian, Shi-Ping Zhang1.
Abstract
BACKGROUND: Acupuncture and moxibustion have widely been used to treat lateral elbow pain (LEP). A comprehensive systematic review of randomized controlled trials (RCTs) including both English and Chinese databases was conducted to assess the efficacy of acupuncture and moxibustion in the treatment of LEP.Entities:
Mesh:
Year: 2014 PMID: 24726029 PMCID: PMC4012509 DOI: 10.1186/1472-6882-14-136
Source DB: PubMed Journal: BMC Complement Altern Med ISSN: 1472-6882 Impact factor: 3.659
Figure 1Flow chart of study selection.
Study design of all included studies
| Chen (2010) [ | 2 parallel arms, follow-up duration not reported | Acupuncture, 1 treatment every 3 days for 15 days | Triamcinolone acetonide injection, 1 treatment every 5 days for 15 days | Local tender points, superficial, strong manual manipulation, needles retained for 1 min. | Triamcinolone acetonide 40 mg, 2% lidocaine 2 ml injected at area of pain |
| Davidson (2001) [ | 2 parallel arms, follow-up duration not reported | Acupuncture, 2–3 treatments per week for 4 weeks | Ultrasound, 2–3 treatments per week for 4 weeks | LI 4, SJ 5, LI 10, LI 11, LI 12, manual manipulation to obtain and maintain De-qi, needles retained for 20 min. | Pulsated ultrasound for 10 min. over area of lateral epicondyle |
| Fink (2002) [ | 2 parallel arms, 2 months | Acupuncture, 2 treatments per week for 5 weeks | Sham-acupuncture, 2 treatments per week for 5 weeks | 1 local tender point, LI 10, LI 11, LU 5, LI 4 and SJ 5, manual manipulation to obtain De-qi, needles retained for 25 min. | Same as treatment group, but needles placed at least 5 cm away from real acupoint, area clear of tender points |
| Grua (1999) [ | 2 parallel arms, follow-up duration not reported | Acupuncture, 1–2 treatments per week for approx. 5 weeks (total of 10 treatments) | Ultrasound, massage, 1 treatment per day for 12 days | LI 4, LI 10, LI 11, LI 12, LI 15, PC 5, PC 7, GB 20, GB 21, GB 34, ST 37, ST 38, manual manipulation needles retained for 20 min. | Pulsated ultrasound for 5 min., massage for 5 min., both at area of lateral epicondyle |
| Irnich (2003) [ | 2 parallel arms, 2 weeks | Acupuncture, 3 treatments for 10 days | Sham-acupuncture, 3 treatments for 10 days | LI 4, LI 10, SI 3, SJ 5, GB 34, intermittent manual manipulation to obtain and maintain De-qi, needles retained for 25 min. | Same as treatment group, but needles placed 1 cun away from real acupoint |
| Jin (2005) [ | 2 parallel arms, 1 month | Single scarring ginger- moxibustion | Prednisolone compound injection, 1 treatment per week for 2 weeks | Local tender points, ginger- moxibustion, 7 cones per acupoint | 2% lidocaine 1 ml, prednisolone 1 ml, Vitamin B1 50 mg, Vitamin B12 250 μg injected at area of pain |
| Li (1998) [ | 2 parallel arms, follow-up duration not reported | AMC, 1 treatment every 1 or 2 days for 2 months | Acupuncture, 1 treatment every 2 days for 2 months | Local tender points, LI 4, LI 10, LI 11, AMC, manual stimulation to obtain and maintain De-qi, needles retained for 15–20 min., moxibustion with moxa-stick until local area reddened | Same as treatment group, but only manual stimulation to obtain and maintain De-qi |
| Li (2007) [ | 2 parallel arms, follow-up duration not reported | Ginger-moxibustion, 1 treatment every 2 days for 14 days | Prednisolone injection, 1 treatment every 5–7 days for 14–21 days | SJ 10, LI 11, manual stimulation to obtain De-qi, needles not retained, ginger-moxibustion 5–7 cones per acupoint | 2% lidocaine 2 ml, prednisolone 25 mg injected at area of pain |
| Liu (2008) [ | 2 parallel arms, follow-up duration not reported | AMC, 1 treatment every 2 days for 28 days | Acupuncture, 1 treatment every 2 days for 28 days | Local tender points, LI 4, LI 10, LI 11, SJ 5, AMC, manual stimulation to obtain and maintain De-qi, needle retained for 20–30 min., indirect moxibustion, 3–5 cones per acupoint | Same as treatment group, but only manual stimulation to obtain and maintain De-qi |
| Lin (2011) [ | 2 parallel arms, 1 month | Acupuncture, 1 treatment every 2 days for 20 days | Prednisolone injection, 1 treatment every 10 days for 20 days | LI 11, 1 most tender point on lateral aspect of elbow, 3 points 0.5-1 cun distal to the most tender point, manual manipulation to obtain and maintain De-qi, needles retained for 30 min. | Prednisolone 5 ml, 2% procaine 1.5 ml injected at area of pain |
| Molsberger (1994) [ | 2 parallel arms, 3 days | Acupuncture, 1 treatment only | Sham-acupuncture, 1 treatment only | Ipsilateral GB 34, manual manipulation to obtain and maintain De-qi, needles retained for 5 min. | BL13 non-needle sham acupuncture, stimulation with a pencil-like probe at beginning and after 5 min. |
| Shen (1999) [ | 3 parallel arms, follow-up duration not reported | Electro-acupuncture, 1 treatment per day for 10 days | Control 1: AMC, 1 treatment per day for 10 days | Local tender points, manual manipulation to obtain De-qi followed by electric stimulation for 30 min., heat lamp for 30 min. | Control 1: Same as treatment group but AMC, needle retainment for 30 min., indirect moxibustion (moxa stick) |
| | | | Control 2: Prednisolone, 1 treatment per week for 3 weeks | | Control 2: Prednisolone 20 mg injected at area of pain |
| Wang (2007) [ | 2 parallel arms, follow-up duration not reported | AMC, 1 treatment per day for 10 days | Acupuncture, 1 treatment per day for 10 days | LI 10, LI 11, SJ 10, PC 6, REN 12, ST 36, SP 6, points chosen based on TCM pattern diagnosis, AMC, De-qi obtained, duration of needle retainment not reported, indirect moxibustion 3 cones per acupoint | Same as treatment group, but only manual stimulation to obtain De-qi, no additional stimulation during treatment, duration of needle retainment not reported |
| Wang (2008) [ | 2 parallel arms, follow-up duration not reported | AMC, 1 treatment every 3 days for 30 days | Acupuncture, 1 treatment every 3 days for 30 days | 5 local tender points, LI 4, AMC, even manual stimulation technique to obtain and maintain De-qi, needles retained for 30 min., indirect moxibustion, 2–3 cones per acupoint | LI 4, LI 10, LI11, LI 12, manual stimulation every 10 min., needles retained for 30 min. |
| Wu (2003) [ | 2 parallel arms, follow-up duration not reported | AMC, 1 treatment every 2 days for 14 days | Acupuncture, 1 treatment every 2 days for 14 days | Local tender points, LI 4, LI 10, LI 11, SJ 5, manual manipulation for 1 min. to obtain and maintain De-qi, needles retained for 30 min., indirect moxibustion 3–5 cones per acupoint | 1 local tender point was selected, De-qi obtained, needles retained for 30 min. |
| Xu (2010) [ | 2 parallel arms, follow-up duration not reported | Single scarring ginger-moxibustion | Prednisolone injection, 1 treatment every 5 days for 15 days | Local tender points, ginger- moxibustion, duration not reported | Prednisolone 25 mg, 2% procaine 2 ml injected at area of pain |
| Zha (2004) [ | 2 parallel arms, follow-up duration not reported | Acupuncture, 1 treatment every 2 days for 14 days | Hydrocortisone acetate injection, 1 treatment per week for two weeks | Local tender points, manual manipulation, duration of needle retainment not reported | 2% lidocaine 5 ml, hydrocortisone-acetate 125 mg (1 ml) injected at area of pain. |
| Zhang (2007) [ | 2 parallel arms, follow-up duration not reported | Acupuncture, 1 treatment every 2 days for 20 days | Meloxicam tablets oral intake, 1 treatment every 2 days for 20 days | 1 local tender point and 2 points at 2 cm apart from the tender point, manual manipulation to obtain and maintain De-qi, duration of needle retainment not reported | Meloxicam tablets 7.5 mg/ day |
| Zhao (2003) [ | 2 parallel arms, follow-up duration not reported | AMC, 1 treatment per day for 10 days | Acupuncture, 1 treatment per day for 10 days | Local tender points, manual manipulation to obtain and maintain De-qi, duration of needle retainment not reported, indirect moxibustion (moxa stick) until local area reddened | Acupuncture at local tender points, manual stimulation, duration of needle retainment not reported |
AMC: acupuncture and moxibustion combined.
Outcomes of randomized controlled trials comparing acupuncture and sham acupuncture
| Fink (2002) [ | Acupuncture | Sham-acupuncture | Strength test (peak muscle force): | | | MD (95% CI) |
| N = 14 | N = 15 | mean ± SD | At baseline: 90.5 ± 40.40 | At baseline: 77.7± 36.40 | 12.80 (−15.26 to 40.86), P = 0.37 | |
| | | | At 2 weeks FU: 128.2 ± 41.64 | At 2 weeks FU: 92.75 ± 34.78 | 35.45 (7.42 to 63.48), P = 0.01* | |
| | | | At 2 months FU: 142.9 ± 41.56 | At 2 months FU: 114.2 ± 46.08 | 28.70 (−3.20 to 60.60), P = 0.08 | |
| | ||||||
| | | Pain (VAS): mean ± SD | At baseline: 16.46 ± 3.10 | At baseline: 17.17 ± 3.76 | −1.24 (−3.74 to 1.26), P = 0.33 | |
| | | | At 2 weeks FU: 8.03 ± 4.60 | At 2 weeks FU: 12.28 ± 4.14 | −4.25 (−7.44 to −1.06), P = 0.009* | |
| | | | At 2 months FU: 6.01 ± 5.09 | At 2 months FU: 8.73 ± 5.03 | −2.72 (−6.41 to 0.97), P = 0.15 | |
| | ||||||
| | | | DASH scores: mean ± SD | At baseline: 38.08 ± 13.66 | At baseline: 33.72 ± 13.05 | 4.36 (−5.38 to 14.10), P = 0.38 |
| | | | At 2 weeks FU: 14.38 ± 9.35 | At 2 weeks FU: 25.18 ± 13.63 | −10.80 (−19.26 to −2.34), P = 0.01* | |
| | | | At 2 months FU: 11.14 ± 13.10 | At 2 months FU: 18.85 ± 13.75 | −7.71 (−17.48 to 2.06), P = 0.12 | |
| Irnich (2003) [ | Acupuncture | Sham-acupuncture | Pressure pain threshold (kg/cm2): | |||
| N = 25 | N = 25 | mean ± SD | At baseline: 3.15 ± 0.69 | At baseline: 2.68 ± 0.65 | 0.47 (0.10 to 0.84), P = 0.01* | |
| | | | At first treatment: 0.32 ± 0.31 | At first treatment: 0.16 ± 0.176 | 0.16 (0.02 to 0.30), P = 0.02* | |
| | | | At last treatment: 0.93 ± 0.49 | At last treatment: 0.63 ± 0.42 | 0.30 (0.05 to 0.55), P = 0.02* | |
| | | | At 2 weeks FU: 1.30 ± 0.60 | At 2 weeks FU: 0.66 ± 0.49 | 0.64 (0.34 to 0.94), P < 0.0001* | |
| | ||||||
| | | Pain-free grip strength: | At baseline: 64.7 ± 34.00 | At baseline: 53.7 ± 17.70 | 11.00 (−4.03 to 26.03), P = 0.15 | |
| | | mean ± SD | At first treatment: 7.12 ± 8.13 | At first treatment: 2.47 ± 3.14 | 4.65 (1.23 to 8.07), P = 0.008* | |
| | | | At last treatment: 21.54 ± 14.35 | At last treatment: 8.53 ± 9.05 | 13.01 (6.36 to 19.66), P = 0.0001* | |
| | | | At 2 weeks FU: 27.95 ± 15.66 | At 2 weeks FU: 7.4 ± 7.90 | 20.55 (13.67 to 27.43), P < 0.00001* | |
| | ||||||
| | | Impairment caused by pain (NRS): | At baseline: 8.19 | At baseline: 7.72 | Calculation of MD not possible | |
| | | | At first treatment: −1.57 | At first treatment: −0.80 | | |
| | | | At last treatment: −4.31 | At last treatment: −2.04* | | |
| | | | At 2 weeks FU: −4.77 (59% mean decrease in impairment caused by pain) | At 2 weeks FU: −1.88* (24% mean decrease in impairment caused by pain) | | |
| | ||||||
| Molsberger (1994) [ | Acupuncture | Sham-acupuncture | 11-point box pain scale (NRS): | Immediately after treatment: | Immediately after treatment: | MD (95% CI) |
| N = 24 | N = 24 | | 55.8% (2.95) mean pain reduction, | 15.0% (2.77) mean pain reduction, | 40.80 (39.18 to 42.42), P < 0.001* | |
| 19/24 subjects reported pain relief of ≥ 50% (NRS ≥ 5) | 6/24 subjects reported pain relief of ≥ 50% (NRS ≥ 5) | RR (95% CI) 3.17 (1.53 to 6.52), P < 0.002* | ||||
*: P < 0.05 statistically significant difference between two groups.
DASH score, Disability of the Arm, Shoulder and Hand score; FU, follow-up; NRS, Numeric Rating Scale; SD, Standard Deviation; MD, Mean Difference; RR, Relative Risk; VAS, Visual Analogue Rating Scale.
Outcomes of randomized controlled trials comparing acupuncture and conventional therapy
| Chen (2010) [ | Acupuncture | Triamcinolone acetonide injection | Pain relief and grip strength: cured rate based on subjective report | 30/33 Cured | 14/33 Cured | RR (95% CI) | |
| Davidson (2001) [ | Acupuncture | Pulsated ultrasound | Pain-free grip strength: mean ± SD | At first treatment: 10.25 ± 5.84 | At first treatment: 6.08 ± 4.19 | MD (95% CI) | |
| | | | At last treatment: 14.09 ± 9.53 | At last treatment: 11.96 ± 12.28 | 2.13 (−8.64 to 12.90), P = 0.70 | ||
| | | Pain Score (VAS): mean ± SD | At first treatment: 39.63 ± 29.51 | At first treatment: 46.50 ± 26.91 | −6.81 (−34.48 to 20.86), P = 0.63 | ||
| | | | At last treatment: 13.63 ± 13.79 | At last treatment: 32.69 ± 29.21 | −19.06 (−41.44 to 3.32), P = 0.10 | ||
| | | DASH score: mean ± SD | At first treatment: 36.35 ± 25.54 | At first treatment: 38.02 ± 15.24 | −1.67 (−22.28 to 18.94), P = 0.87 | ||
| | | | At last treatment: 23.75 ± 17.73 | At last treatment: 33.23 ± 24.06 | −9.48 (−30.19 to 11.23), P = 0.37 | ||
| | | | At 4 week FU: 23.75 ± 18.41 | At 4 week FU: 22.40 ± 18.73 | 1.35 (−16.85 to 19.55), P = 0.88 | ||
| Grua (1999) [ | Acupuncture | Pulsated ultrasound, massage | Maigne functional recovery test: mean ± SD | At first visit: 15.0 ± 2.36 | At first visit: 15.0 ± 2.70 | MD (95% CI) | |
| | At last treatment: 5.80 ± 3.37 | At last treatment: 9.80 ± 3.65 | −4.00 (−6.18 to −1.82), P = 0.0003* | ||||
| | | | At 6 months FU: 5.20 ± 3.64 | At 6 months FU: 10.0 ± 3.45 | −4.80 (−7.00 to −2.60, P < 0.0001* | ||
| | | Pain Score(VAS): mean ± SD | At first visit: 7.05 ± 1.47 | At first visit: 7.05 ± 1.39 | 0.00 (−0.89 to 0.89), P = 1.00 | ||
| | | | At last treatment: 2.85 ± 1.81 | At last treatment: 4.49 ± 1.64 | −1.64 (−2.71 to −0.57), P = 0.003* | ||
| | | | At 6 months FU: 2.05 ± 1.39 | At 6 months FU: 4.90 ± 1.45 | −2.85 (−3.73 to −1.97), P < 0.00001* | ||
| Lin (2011) [ | Acupuncture | Prednisolone injection | Pain relief: VAS, cured rate based on subjective report | 20/36 Cured | 13/36 Cured | RR (95% CI) | |
| Shen (1999) [ | Electro-acupuncture | Prednisolone injection | Pain relief and range of movement: cured rate based on subjective report | 32/41 Cured | 7/20 Cured | RR (95% CI) | |
| Zha (2004) [ | Acupuncture | Hydrocortisone injection | Pain relief and range of movement: cured rate based on ADL score | 8/57 Cured | 6/60 Cured | RR (95% CI) | |
| Zhang (2007) [ | Acupuncture | Meloxicam tablets | Pain relief and range of movement: cured rate based on subjective report | 26/36 Cured | 15/32 Cured | RR (95% CI) | |
*: P < 0.05 statistically significant difference between two groups. **: Outcomes were measured at the end of last treatment, except for those specifically mentioned.
ADL, Activities of daily living scale; 95% CI, 95% Confidence Interval; DASH score, Disability of the Arm, Shoulder and Hand score; FU, follow-up; RR, Relative Risk; SD, Standard Deviation; MD, Mean Difference; VAS, Visual Analogue Rating Scale.
Outcomes of randomized controlled trials comparing moxibustion and conventional therapy
| Jin (2005) [ | Ginger- moxibustion | Prednisolone injection | Pain relief and range of movement: cured rate based on ADL score | 59/80 | 17/32 | 1.39 (0.98 to 1.97) |
| N = 80 | N = 32 | 73.8% | 53.1% | P = 0.07 | ||
| | ||||||
| Li (2007) [ | Ginger- moxibustion | Prednisone injection | Pain relief and grip strength: cured rate based on subjective report | 20/25 | 21/25 | 0.95 (0.73 to 1.24) |
| N = 25 | N = 25 | 80% | 84% | P = 0.71 | ||
| | ||||||
| Xu (2010) [ | Ginger- moxibustion | Prednisone injection | Pain relief and grip strength: cured rate based on subjective report | 11/23 | 4/22 | 2.63 (0.98 to 7.04) |
| N = 23 | N = 22 | 47.8% | 18.2% | P = 0.05 | ||
**: Outcomes were measured at the end of last treatment, except for those specifically mentioned.
ADL, Activities of daily living scale; 95% CI, 95% Confidence Interval; RR, Relative Risk.
Outcomes of randomized controlled trials comparing Acupuncture and Moxibustion Combined (AMC) with acupuncture
| Li (1998) [ | AMC | Acupuncture | Pain relief: cured rate based on subjective report | 49/60 | 15/30 | 1.63 (1.12 to 2.38) |
| N = 60 | N = 30 | 81.7% | 50% | P = 0.01* | ||
| | ||||||
| Liu (2008) [ | AMC | Acupuncture | Pain relief and range of movement: cured rate based on subjective report | 28/37 | 6/26 | 3.28 (1.58 to 6.77) |
| N = 37 | N = 26 | 76% | 23% | P = 0.0013* | ||
| | ||||||
| Shen (1999) [ | AMC | Electro-acupuncture | Pain relief and range of movement: cured rate based on subjective report | 10/27 | 32/41 | 0.47 (0.28 to 0.80) |
| N = 27 | N = 41 | 37% | 78% | P = 0.005* | ||
| | ||||||
| Wang (2007) [ | AMC | Acupuncture | Pain relief and range of movement: cured rate based on subjective report | 22/36 | 9/36 | 2.44 (1.31 to 4.56) |
| N = 36 | N = 36 | 61.1% | 25% | P = 0.005* | ||
| | ||||||
| Wang (2008) [ | AMC | Acupuncture | Pain relief and range of movement: cured rate based on subjective report | 15/32 | 6/32 | 2.50 (1.11 to 5.62) |
| N = 32 | N = 32 | 46.9% | 18.8% | P = 0.03* | ||
| | ||||||
| Wu (2003) [ | AMC | Acupuncture | Pain relief and range of movement: cured rate based on subjective report | 56/74 | 13/52 | 3.03 (1.86 to 4.93) |
| N = 74 | N = 52 | 75% | 25% | P < 0.0001* | ||
| | ||||||
| Zhao (2003) [ | AMC | Acupuncture | Pain relief and range of movement: cured rate based on subjective report | 23/25 | 16/24 | 1.38 (1.02 to 1.87) |
| N = 25 | N = 24 | 92% | 66.6% | P = 0.04* | ||
*: P < 0.05 statistically significant difference between two groups. **: Outcomes were measured at the end of last treatment, except for those specifically mentioned.
95% CI, 95% Confidence Interval; AMC, acupuncture and moxibustion combined; RR, Relative Risk.
Appraisal of acupuncture and moxibustion procedure based on the revised SRICTA criteria (2010)
| | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chen (2010) [ | TCM | Y | NR | Y | Y | Y | Y | NR | Y | NR | NR | NR | Y |
| Davidson (2001) [ | TCM | Y | Y | Y | Y | Y | Y | Y | Y | NR | NR | NR | Y |
| Fink (2002) [ | TCM | Y* | Y | NR | Y | NR | Y | Y | Y | NR | NR | Y | Y |
| Grua (1999) [ | TCM | Y | Y | NR | NR | Y | Y | NR | Y | Y | NR | Y | Y |
| Irnich (2003) [ | TCM | Y | Y | NR | NR | Y | Y | NR | Y | NR | NR | NR | Y |
| Jin (2005) [ | TCM | Y | NR | NR | Y | Y | NR | NA | Y | NA | NA | NR | Y |
| Li (1998) [ | TCM | Y | NR | NR | Y | Y | Y | NA | Y | NA | NA | NR | Y |
| Li (2007) [ | TCM | Y | Y | Y | Y | NR | NR | Y | Y | Y | Y | NR | Y |
| Liu (2008) [ | TCM | Y | NR | Y | Y | Y | Y | Y | Y | Y | Y | NR | Y |
| Lin (2011) [ | TCM | Y | Y | Y | Y | Y | Y | Y | Y | NR | NR | NR | Y |
| Molsberger (1994) [ | TCM | Y* | Y | Y | Y | Y | Y | NR | NR | NR | NR | Y | Y |
| Shen (1999) [ | TCM | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | NR | Y |
| Wang (2007) [ | TCM | Y | NR | NR | Y | Y | NR | NR | Y | Y | Y | NR | Y |
| Wang (2008) [ | TCM | Y | Y | NR | Y | Y | Y | Y | Y | Y | Y | NR | Y |
| Wu (2003) [ | TCM | Y | NR | Y | Y | Y | Y | Y | Y | Y | Y | NR | Y |
| Xu (2010) [ | TCM | Y | NR | NR | NR | NR | NR | NA | NR | NA | NA | NR | Y |
| Zha (2004) [ | TCM | Y | Y | Y | NR | Y | Y | Y | Y | NR | NR | NR | Y |
| Zhang (2007) [ | TCM | Y | Y | Y | Y | Y | NR | Y | Y | NR | NR | NR | Y |
| Zhao (2003) [ | TCM | Y | NR | Y | Y | Y | NR | Y | Y | Y | Y | NR | Y |
NA, not applicable; NR not reported; TCM, acupoint selection based on TCM theory; Y, reported; Y*reported and mentioned if unilateral or bilateral needle placement.
Cochrane risk of bias assessment
| Chen (2010) [ | Unclear | Unclear | High | Low | Low | Low |
| Davidson (2001) [ | Low | Unclear | High | Low | Low | Low |
| Fink (2002) [ | Low | Unclear | Low | Low | Low | Low |
| Grua (1999) [ | Unclear | Unclear | High | Low | Low | Low |
| Irnich (2003) [ | High | High | Low | Low | Low | High |
| Jin (2005) [ | Unclear | Unclear | High | Low | Low | Low |
| Li (1998) [ | Unclear | Unclear | High | Low | Low | Unclear |
| Li (2007) [ | Unclear | Unclear | High | Low | Low | Low |
| Liu (2008) [ | Unclear | Unclear | High | Low | Low | Unclear |
| Lin (2011) [ | Unclear | Unclear | High | Low | Low | Low |
| Molsberger (1994) [ | Unclear | Unclear | High | Low | Low | Low |
| Shen (1999) [ | Unclear | Unclear | High | Low | Low | Unclear |
| Wang (2007) [ | High | High | High | Low | Low | Low |
| Wang (2008) [ | Unclear | Unclear | High | Low | Low | Low |
| Wu (2003) [ | Unclear | Unclear | High | Low | Low | Low |
| Xu (2010) [ | Unclear | Unclear | High | Low | Low | Unclear |
| Zha (2004) [ | Low | Unclear | High | Low | Low | Low |
| Zhang (2007) [ | Low | High | High | Low | Low | Low |
| Zhao (2003) [ | High | High | High | Low | Low | Unclear |